Navigation Links
OEV-203 Monitors

ProductsOEV-203 Monitors
Company Olympus America Medical
Item OEV-203 Monitors
Features 
  • Analog RGB, Y/C, and composite video inputs, easy-to-operate, on-screen menu simplifies control functions.
  • Control knobs offer convenient access to settings for contrast, brightness, aperture, phase and chroma.
  • RGB split screen mode allows two RGB inputs to be observed simultaneously, ideal for setting printer color.
  • Normal, overscan and underscan modes provide for a variety of image sizes.
  • Safe design and cover for front panel prevents accidental setting changes.
Description The OEV-203 Monitors are designed exclusively for video endoscopy and are ideal components for use with all Olympus endoscopy systems. When used in conjunction with our innovative endoscopic equipment, the OEV-203 provides sharp, high-resolution images with excellent color reproduction to provide you with the view - and details - necessary for accurate diagnosis. They provide great image flexibility thanks to a variety of adjustable features - controlled via conveniently located front panel knobs - and are easy to operate due to a simplified on-screen menu.
Info Olympus America Medical
Customer Service: (800) 848-9024
Web site: http://www.olympusamerica.com

Related medicine products :

1. Video Monitors
2. OEV-143 Monitors
3. Screenline LCD Monitors
Other Medicine News:Health News:Maternal Mortality Declining in Middle-income Countries; Women Still Die in Pregnancy and Childbirth in Low-income Countries 2Health News:Maternal Mortality Declining in Middle-income Countries; Women Still Die in Pregnancy and Childbirth in Low-income Countries 3Health News:Nasdaq Informs Synutra that the Company's Filing Delinquency has been Cured 2Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 2Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 3Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 4Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 5Health News:KV Pharmaceutical Company Reports Results of Special Independent Committee Review of Stock Option Grants 6Health News:American Psychiatric Foundation Hosts a Benefit for New Orleans Mental Health Organizations as a Part of the Institute for Psychiatric Services Conference 2Health News:New research may show why some prostate cancer recurs after treatment 2Health News:New research may show why some prostate cancer recurs after treatment 3Health News:The era of global aging: GSA showcases cutting-edge San Francisco meeting topics 2Health News:The era of global aging: GSA showcases cutting-edge San Francisco meeting topics 3
Breaking Medicine Technology:Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 2Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 3Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 4Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 5Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 6Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 7Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 8Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 9Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 10Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 11Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 12Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 13Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 14Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 15Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 16Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 17Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance 18Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress 2Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress 3Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress 4Masimo Receives 2009 Zenith Award at the American Association of Respiratory Care Congress 5Maxim Health Systems to Provide 44 000 Flu Shot Clinics Nationwide 3B Flu Vaccinations Begin on October 1 56447 1Maxim Health Systems to Provide 44 000 Flu Shot Clinics Nationwide 3B Flu Vaccinations Begin on October 1 56447 2Maxim Health Systems to Provide 44 000 Flu Shot Clinics Nationwide 3B Flu Vaccinations Begin on October 1 56447 3Maxim Health Systems to Provide 44 000 Flu Shot Clinics Nationwide 3B Flu Vaccinations Begin on October 1 56447 4Inventor of Green Catalysts Offers Solutions for Cleaning Toxins and Pollutants in the Environment 56443 1Inventor of Green Catalysts Offers Solutions for Cleaning Toxins and Pollutants in the Environment 56443 2BHR Pharma Announces Phase 3 SyNAPSe Study of Progesterone as a Neuroprotective Agent for Traumatic Brain Injury 4954 1BHR Pharma Announces Phase 3 SyNAPSe Study of Progesterone as a Neuroprotective Agent for Traumatic Brain Injury 4954 2